• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease.修订版 SCOPA-Diary 卡的心理测量验证:扩展帕金森病非运动症状的测量。
Health Qual Life Outcomes. 2011 Aug 18;9:69. doi: 10.1186/1477-7525-9-69.
2
Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial questionnaire (SCOPA-PS) in four Latin American countries.在四个拉丁美洲国家中对帕金森病心理社会结局量表(SCOPA-PS)进行跨文化验证。
Value Health. 2009 Mar-Apr;12(2):385-91. doi: 10.1111/j.1524-4733.2008.00436.x. Epub 2008 Jul 24.
3
Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study.使用SCOPA-PS评估接受DBS-STN治疗的法国帕金森病患者的健康相关生活质量:一项验证研究。
Rev Neurol (Paris). 2016 Apr-May;172(4-5):281-8. doi: 10.1016/j.neurol.2015.10.010. Epub 2016 May 2.
4
[Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].[帕金森病心理社会结局量表(SCOPA-PS)的心理测量属性:西班牙的验证及综述]
Rev Neurol. 2009;49(1):1-7.
5
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.帕金森病非运动症状量表心理测量属性的国际研究。
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.
6
[Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].[帕金森病认知功能评定量表(SCOPA-Cog)西班牙语版的心理测量学属性]
Rev Neurol. 2008;47(7):337-43.
7
Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.SCOPA-Sleep-德语版的跨文化调适和心理测量特性。
Neurol Sci. 2018 Jul;39(7):1225-1230. doi: 10.1007/s10072-018-3397-z. Epub 2018 Apr 14.
8
Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.帕金森病睡眠结局量表(韩文版)的验证。
J Korean Med Sci. 2018 Jan 8;33(2):e14. doi: 10.3346/jkms.2018.33.e14.
9
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.SCOPA睡眠量表和帕金森病睡眠量表:两种评估帕金森病睡眠障碍的量表。
Mov Disord. 2008 Sep 15;23(12):1681-8. doi: 10.1002/mds.22110.
10
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.一种用于评估帕金森病运动障碍和残疾程度的简短量表:SPES/SCOPA量表
J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):388-95. doi: 10.1136/jnnp.2003.017509.

引用本文的文献

1
Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol.帕金森病患者生物钟的分子特征研究方案-CLOCK4PD 研究方案。
PLoS One. 2024 Jul 19;19(7):e0305712. doi: 10.1371/journal.pone.0305712. eCollection 2024.
2
Longitudinal investigation of the factor structure of the Parkinson's disease activities of daily living, interference and dependence instrument.帕金森病日常生活活动、干扰与依赖量表因素结构的纵向研究。
Front Neurol. 2022 Sep 23;13:941788. doi: 10.3389/fneur.2022.941788. eCollection 2022.
3
Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.2012 年帕金森病的非运动症状:相关临床方面。
Parkinsons Dis. 2012;2012:198316. doi: 10.1155/2012/198316. Epub 2012 Jul 25.

本文引用的文献

1
Constructing validity: New developments in creating objective measuring instruments.结构效度:客观测量工具的新发展。
Psychol Assess. 2019 Dec;31(12):1412-1427. doi: 10.1037/pas0000626. Epub 2019 Mar 21.
2
Scales for assessing nonmotor symptom severity changes in Parkinson's disease patients with symptom fluctuations.用于评估帕金森病患者症状波动时非运动症状严重程度变化的量表。
Int J Neurosci. 2010 Aug;120(8):523-30. doi: 10.3109/00207454.2010.489725.
3
Non-motor symptoms in Parkinson's disease.帕金森病的非运动症状
J Neurol. 2009 Aug;256 Suppl 3:293-8. doi: 10.1007/s00415-009-5240-1.
4
Nonmotor manifestations of Parkinson's disease.帕金森病的非运动症状
Ann Neurol. 2008 Dec;64 Suppl 2:S65-80. doi: 10.1002/ana.21472.
5
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.运动障碍协会赞助的统一帕金森病评定量表修订版(MDS-UPDRS):量表介绍及临床测量测试结果
Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.
6
A comprehensive model of health-related quality of life in Parkinson's disease.帕金森病健康相关生活质量的综合模型。
J Neurol. 2008 Oct;255(10):1580-7. doi: 10.1007/s00415-008-0994-4. Epub 2008 Sep 24.
7
A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease.帕金森病患者健康相关生活质量的纵向评估。
Value Health. 2009 Mar-Apr;12(2):392-6. doi: 10.1111/j.1524-4733.2008.00430.x. Epub 2008 Jul 24.
8
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.新型药物治疗对帕金森病患者生活质量的影响。
CNS Drugs. 2008;22(7):563-86. doi: 10.2165/00023210-200822070-00003.
9
Predictors and course of health-related quality of life in Parkinson's disease.帕金森病中与健康相关生活质量的预测因素及病程
Mov Disord. 2008 Jul 30;23(10):1420-7. doi: 10.1002/mds.22121.
10
Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families.帕金森病的非运动症状:患者及家属的患病率与知晓情况
Parkinsonism Relat Disord. 2008;14(4):286-90. doi: 10.1016/j.parkreldis.2007.09.002. Epub 2007 Nov 26.

修订版 SCOPA-Diary 卡的心理测量验证:扩展帕金森病非运动症状的测量。

Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease.

机构信息

QualityMetric Inc, Lincoln, RI, USA.

出版信息

Health Qual Life Outcomes. 2011 Aug 18;9:69. doi: 10.1186/1477-7525-9-69.

DOI:10.1186/1477-7525-9-69
PMID:21851616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3173285/
Abstract

BACKGROUND

To identify key non-motor symptoms of Parkinson's disease (PD) to include in a daily diary assessment for off-time, revise the Scales for Outcomes of Parkinson's disease Diary Card (SCOPA-DC) to include these non-motor symptoms, and investigate the validity, reliability and predictive utility of the Revised SCOPA-DC in a U.S. population.

METHODS

A convenience sample was used to recruit four focus groups of PD patients. Based on findings from focus groups, the SCOPA-DC was revised and administered to a sample of 101 PD patients. Confirmatory factor analysis was conducted to test the domain structure of the Revised SCOPA-DC. The reliability, convergent and discriminant validity, and ability to predict off-time of the Revised SCOPA-DC were then assessed.

RESULTS

Based on input from PD patients, the Revised SCOPA-DC included several format changes and the addition of non-motor symptoms. The Revised SCOPA-DC was best represented by a three-factor structure: Mobility, Physical Functioning and Psychological Functioning. Correlations between the Revised SCOPA-DC and other Health-Related Quality of Life scores were supportive of convergent validity. Known-groups validity analyses indicated that scores on the Revised SCOPA-DC were lower among patients who reported experiencing off-time when compared to those without off-time. The three subscales had satisfactory predictive utility, correctly predicting off-time slightly over two-thirds of the time.

CONCLUSIONS

These findings provide evidence of content validity of the Revised SCOPA-DC and suggest that a three-factor structure is an appropriate model that provides reliable and valid scores to assess symptom severity among PD patients with symptom fluctuations in the U.S.

摘要

背景

为了确定帕金森病(PD)的关键非运动症状,以便纳入非运动症状的失代偿时间日常日记评估中,修订帕金森病日记卡量表(SCOPA-DC)以纳入这些非运动症状,并研究修订后的 SCOPA-DC 在美 国人群中的有效性、可靠性和预测实用性。

方法

使用便利样本招募了四组 PD 患者焦点小组。基于焦点小组的研究结果,修订了 SCOPA-DC,并对 101 名 PD 患者进行了评估。采用验证性因子分析对修订后的 SCOPA-DC 的结构进行了测试。然后评估了修订后的 SCOPA-DC 的可靠性、收敛和判别有效性,以及预测失代偿时间的能力。

结果

基于 PD 患者的意见,修订后的 SCOPA-DC 包括了一些格式变化和非运动症状的增加。修订后的 SCOPA-DC 最好由三个因素结构表示:运动、身体功能和心理功能。修订后的 SCOPA-DC 与其他健康相关生活质量评分之间的相关性支持了收敛有效性。已知组有效性分析表明,与没有失代偿时间的患者相比,报告出现失代偿时间的患者的修订后 SCOPA-DC 评分较低。三个子量表具有令人满意的预测实用性,正确预测失代偿时间的比例略高于三分之二。

结论

这些发现为修订后的 SCOPA-DC 的内容有效性提供了证据,并表明三因素结构是一种合适的模型,可提供可靠有效的评分来评估美国有症状波动的 PD 患者的症状严重程度。